Junior Hall

1.0k total citations
11 papers, 624 citations indexed

About

Junior Hall is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Junior Hall has authored 11 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Junior Hall's work include Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). Junior Hall is often cited by papers focused on Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). Junior Hall collaborates with scholars based in United States, Australia and United Kingdom. Junior Hall's co-authors include Stephan A. Grupp, David T. Teachey, Alix E. Seif, Cecilia Sheen, Theresa Ryan, Charles G. Mullighan, Stephen P. Hunger, Mignon L. Loh, Tiffaney L. Vincent and Shannon L. Maude and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cell Cycle.

In The Last Decade

Junior Hall

10 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junior Hall United States	6	342	316	166	160	130	11	624
Wolf-Dieter Ludwig Germany	9	393 1.1×	318 1.0×	168 1.0×	96 0.6×	49 0.4×	12	587
Sandra Heesch Germany	15	376 1.1×	368 1.2×	382 2.3×	104 0.7×	74 0.6×	21	777
Linda Holmfeldt United States	8	281 0.8×	275 0.9×	393 2.4×	141 0.9×	106 0.8×	14	740
Debbie Payne-Turner United States	6	473 1.4×	423 1.3×	272 1.6×	119 0.7×	51 0.4×	14	770
Ruta Grebliunaite United States	5	304 0.9×	278 0.9×	332 2.0×	117 0.7×	86 0.7×	6	623
Jessica G. C. A. M. Buijs-Gladdines Netherlands	12	628 1.8×	508 1.6×	407 2.5×	183 1.1×	167 1.3×	24	1.0k
Christian Hurtz United States	10	162 0.5×	258 0.8×	246 1.5×	115 0.7×	151 1.2×	32	607
PH Sorensen Canada	6	275 0.8×	335 1.1×	255 1.5×	73 0.5×	75 0.6×	7	556
Eulàlia Genescà Spain	11	216 0.6×	151 0.5×	242 1.5×	193 1.2×	81 0.6×	24	518
Monique Passier Netherlands	10	187 0.5×	144 0.5×	260 1.6×	99 0.6×	52 0.4×	11	490

Countries citing papers authored by Junior Hall

Since Specialization

Citations

This map shows the geographic impact of Junior Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junior Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junior Hall more than expected).

Fields of papers citing papers by Junior Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junior Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junior Hall. The network helps show where Junior Hall may publish in the future.

Co-authorship network of co-authors of Junior Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Junior Hall. A scholar is included among the top collaborators of Junior Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junior Hall. Junior Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Talekar, Mala K., Junior Hall, Gerald Wertheim, et al.. (2017). Effect of ONC201 and bortezomib on apoptosis in non-Hodgkin's lymphoma (NHL) xenografts.. Journal of Clinical Oncology. 35(15_suppl). e19016–e19016. 1 indexed citations

Prabhu, Varun V., Mala K. Talekar, Amriti R. Lulla, et al.. (2017). Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies. Cell Cycle. 17(4). 468–478. 33 indexed citations

Maude, Shannon L., Sibasish Dolai, Cristina Delgado-Martín, et al.. (2015). Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. Blood. 125(11). 1759–1767. 158 indexed citations

Maude, Shannon L., Sarah K. Tasian, Tiffaney L. Vincent, et al.. (2012). Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood. 120(17). 3510–3518. 196 indexed citations

Maude, Shannon L., Sarah K. Tasian, Tiffaney L. Vincent, et al.. (2011). Targeting mTOR and JAK2 in Xenograft Models of CRLF2-Overexpressing Acute Lymphoblastic Leukemia (ALL). Blood. 118(21). 249–249. 3 indexed citations

Teachey, David T., Cecilia Sheen, Junior Hall, et al.. (2008). mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia. Blood. 112(5). 2020–2023. 91 indexed citations

Teachey, David T., Alix E. Seif, Valerie I. Brown, et al.. (2007). Targeting Notch signaling in autoimmune and lymphoproliferative disease. Blood. 111(2). 705–714. 69 indexed citations

Teachey, David T., Alix E. Seif, Junior Hall, et al.. (2006). Targeting Notch Signaling as a Safe and Effective Treatment for Autoimmune and Lymphoproliferative Diseases.. Blood. 108(11). 647–647. 1 indexed citations

Teachey, David T., Kelly Axsom, John Choi, et al.. (2006). Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Blood. 108(6). 1965–1971. 69 indexed citations

10.

Beuvink, Iwan, Anne Boulay, Stefano Fumagalli, et al.. (2004). 40 RAD001 sensitizes tumor cells to cisplatin-induced apoptosis in an mTOR dependent manner by inhibition of p53-induced p21 protein expression. European Journal of Cancer Supplements. 2(8). 16–16. 1 indexed citations

11.

Hall, Junior, et al.. (1961). The effect of 6-mercaptopurine riboside in 20 cases of childhood leukemia previously treated with purine antimetabolites.. PubMed. 14. 121–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact